Last updated on November 2017

A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)


Brief description of study

A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)

Detailed Study Description

Hormone Deficiencies

Clinical Study Identifier: TX15618

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Betsy Moclair

Manhattan Medical Research
New York, NY USA
  Connect »